Guanfacine hydrochloride

Details

Files

Generic Name:

Guanfacine hydrochloride

Project Status:

Complete

Therapeutic Area:

Attention-deficit/hyperactivity disorder (ADHD)

Manufacturer:

Shire Canada Inc.

Call for patient/clinician input open:

July 29, 2013

Brand Name:

Intuniv XR

Project Line:

Reimbursement Review

Project Number:

SR0349-000

Call for patient/clinician input closed:

September 18, 2013

NOC Status at Filing:

Post NOC

Submission Type:

Initial

Indications:

Attention-deficit/hyperactivity disorder (ADHD)

Recommendation Type:

Do not list

Final Recommendation:

September 24, 2014

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Last Updated : August 27, 2013